Stoke Therapeutics, Inc.

STOK

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001623526

SEC filings (opens in a new tab)

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Stoke Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of STOK: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	118	1	130	+13
Shares	58.2M	70	58.1M	−152.2K (−0.3%)
Value	$715.5M	$861	$640.4M	−$75.0M (−10.5%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Stoke Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to STOK in Q4 2024
Institution	Shares	Value	% of portfolio
Toronto Dominion Bank	3,173,258	$35.0M	0.07%
Siren, L.L.C.	2,000,000	$22.1M	0.97%
Norges Bank	314,800	$3.47M	0.00%
Tang Capital Management LLC	300,000	$3.31M	0.22%
Schonfeld Strategic Advisors LLC	291,795	$3.22M	0.02%
Renaissance Technologies LLC	129,043	$1.42M	0.00%
Panagora Asset Management Inc	104,272	$1.15M	0.01%
Alps Advisors Inc	42,830	$472.4K	0.00%
EntryPoint Capital, LLC	31,968	$352.6K	0.15%
Opaleye Management Inc.	25,000	$275.8K	0.05%
Tudor Investment Corp Et Al	18,258	$201.4K	0.00%
Freestone Grove Partners LP	18,049	$199.1K	0.00%
Verition Fund Management LLC	15,160	$167.2K	0.00%
ProShare Advisors LLC	12,626	$139.3K	0.00%
Invesco Ltd.	12,065	$133.1K	0.00%
China Universal Asset Management Co., Ltd.	11,231	$123.9K	0.01%
Teacher Retirement System of Texas	10,219	$113.0K	0.00%
Police & Firemen's Retirement System of New Jersey	7,174	$79.1K	0.00%
KLP Kapitalforvaltning AS	5,700	$62.9K	0.00%
Mirae Asset Global Investments Co., Ltd.	1,765	$19.5K	0.00%
GF Fund Management Co. Ltd.	1,112	$12.3K	0.00%
Valley National Advisers Inc	750	$8.00K	0.00%
Versant Capital Management, Inc	560	$6.18K	0.00%
R Squared Ltd	440	$4.85K	0.00%
Daiwa Securities Group Inc.	175	$2.00K	0.00%
Caitong International Asset Management Co., Ltd	59	$651	0.00%
SBI Securities Co., Ltd.	9	$99	0.00%
IFP Advisors, Inc	6	$66	0.00%
EverSource Wealth Advisors, LLC	3	$33	0.00%

Sold out (16)

Institutions that held Stoke Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of STOK in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Cowen and Company, LLC	3,244,498	$39.9M
Element Capital Management LLC	96,380	$1.18M
Eversept Partners, LP	52,006	$639.2K
EAM Investors, LLC	30,781	$378.3K
Qube Research & Technologies Ltd	21,432	$263.4K
Two Sigma Advisers, LP	14,500	$178.2K
Arrowstreet Capital, Limited Partnership	13,337	$163.9K
HRT Financial LP	11,955	$146.0K
Acadian Asset Management LLC	1,845	$22.0K
Stone House Investment Management, LLC	500	$6.14K
True Wealth Design, LLC	139	$1.71K
Northwestern Mutual Wealth Management Co	119	$1.46K
Capital Performance Advisors LLP	32	$393
Lindbrook Capital, LLC	30	$369
Quest Partners LLC	2	$25
Bessemer Group Inc	15	$0

Not filed for Q4 2024 yet (1)

Institutions that held Stoke Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STOK in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Planning Capital Management Corp	70	$861